ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - phenazone; tetracaine hydrochloride - טיפות - phenazone 5 %w/w; tetracaine hydrochloride 0.5 %w/w - tetracaine - tetracaine - relief of pain in acute otitis media.

ישראל - עברית - Ministry of Health

אלדן ציוד אלקטרוני בע"מ - רופא - מכשיר ממוגרפיה

ישראל - עברית - Ministry of Health

vitamed pharmaceutical industries ltd - phenazone; tetracaine hydrochloride - טיפות - tetracaine hydrochloride 0.5 %w/w; phenazone 5 %w/w - combinations - combinations - for the relief of pain in acute otitis media and the external, auditory canal.

ישראל - עברית - Ministry of Health

intervet ( israel) ltd - embutramide; mebezonium; tetracaine hydrochloride - תמיסה להזרקה - embutramide 200 mg/ml; mebezonium 50 mg/ml; tetracaine hydrochloride 5 mg/ml

ישראל - עברית - Ministry of Health

syneron medical - אחר - "the co2re system is indicated for use in the performance of dermatological procedures requiring ablation, coagulation and resurfacing of soft tissue, including skin."

ישראל - עברית - Ministry of Health

syneron medical - אחר - the co2re system is indicated for use in the performance of dermatological procedures requiring ablation, coagulation and resurfacing of soft tissue, including skin.

ישראל - עברית - Ministry of Health

sarel - כלל האוכלוסיה - תחבושות אלסטיות קרות

ישראל - עברית - Ministry of Health

לילית קוסמטיקה בעמ - לחות לפנים

ישראל - עברית - Ministry of Health

romat ltd - enrofloxacin - תמיסה (פומי) - enrofloxacin 100 mg / 1 ml

ישראל - עברית - Ministry of Health

roche pharmaceuticals (israel) ltd - trastuzumab - תמיסה לאינפוזיה - trastuzumab 440 mg/ml - trastuzumab - trastuzumab - herceptin is indicated for the treatment of patients with metastatic breast cancer who have tumours that overexpress her2: 1. as a single agent for the treatment of those patients who have received one or more chemotherapy regiments for their metastatic disease. 2. in combination with paclitaxel or docetaxel for the treatment of those patients who have not received chemotherapy for their metastatic disease. 3. herceptin in combination with an aromatase inhibitor for the treatment of postmenopausal patients with hormone-receptor positive metastatic breast cancer. early breast cancer (ebc) :herceptin is indicated to treat patients with her2-positive early breast cancer following surgery and chemotherapy (neoadjuvant or adjuvant) either alone or in combination with chemotherapy excluding anthracyclines. herceptin should only be used in patients whose tumors have either her2 overexpression or her2 gene amplification as determined by an accurate and validated assay.her2 metastatic gastric cancer (mgc)herceptin in